Maha FDA Yet To Set Up NPPA Cell To Detect Ceiling Price Violation

The Maharashtra Food and Drug Administration (FDA) is yet to set up an NPPA cell to deal with the drug price ceiling violation at its headquarters in Mumbai for want…

USFDA recommends regulatory action after Jubilant Life’s Roorkee plant inspection

New Delhi: The US health regulator has recommended a regulatory or administrative action after the inspection of Roorkee manufacturing facility of drug firm Jubilant Life Sciences, according to a regulatory…

AstraZeneca’s Imfinzi fails to meet main goals in head and neck cancer study

AstraZeneca Plc’s immunotherapy treatment Imfinzi did not meet the main goals in a late-stage study for advanced head and neck cancer, the London-listed drugmaker said on Friday. The study, known…

Moderna, largest biotech to go public, fails to impress in market debut

Moderna Inc’s shares fell as much as 6 percent in an upsized market debut on Friday, taking a hit from a broader selloff in the U.S. markets spurred by investors…

VAT scam: Pharmaceutical firm vice-chairman in judicial custody

CHANDIGARH: The district court remanded N R Munjal, vice-chairman, Ind-Swift pharma firm, to 14-day judicial custody. Munjal was arrested for his alleged involvement in the VAT evasion scam that rocked…

AstraZeneca Pharma inks distribution pact with Abbott for diabetes drug

New Delhi: Drug firm AstraZeneca Pharma India Friday said it has entered into a distribution agreement with Abbott Healthcare for distribution of diabetes medicine Dapagliflozin in India. Dapagliflozin, an innovative…

Bugworks Research set for pre-clinical drug trials

BENGALURU: Bugworks Research, a Bengaluru-based drug discovery startup, has moved a few steps closer to its goal of developing next-generation antibiotics. Its drug candidate is set to enter pre-clinical trials…

Moderna to raise $618 mln in upsized IPO, braving market jitters

By Lance Tupper and Joshua Franklin Moderna Inc is set to sell around $618 million in shares in its initial public offering (IPO) on Thursday, a person familiar with the…

Drug company Actelion to pay $360M in kickback probe

BOSTON: A pharmaceutical company has agreed to pay $360 million to resolve allegations that it used a charitable foundation to pay kickbacks to Medicare patients. The U.S. attorney’s office in…

Effective drug for Parkinson’s now available in Bengaluru

Vikram Hospital, in association with the UK-based speciality pharmaceutical company Britannia Pharmaceuticals, has launched ‘Apomorphine’ for the first time in the country. According to the hospital, this powerful new drug…